Figure 5From: Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients Peak intensity of the m/z 9198 marker (as determined by SELDI-TOF MS) vs. haptoglobin phenotype (as assessed by 1D gel-electrophoresis) of samples in set I.Back to article page